Novel immune-based treatment strategies for chronic lymphocytic leukemia.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16155015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immune-based treatments represent a new group of therapeutic strategies for patients with cancer, including chronic lymphocytic leukemia (CLL), that employ immune effector mechanisms. Among these strategies is passive immunotherapy with monoclonal antibody, alone or in combination with chemotherapy. Active immunotherapy strategies currently under development include vaccines, administration of expanded and activated T cells, and allogeneic stem cell transplantation. These immune-based strategies represent new treatments with potentially complementary mechanisms of action to standard therapies and signify major advances in treatments for patients with CLL.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Immunotherapy
- Leukemia, Lymphocytic, Chronic, B-Cell